Hologram Sciences to Showcase Innovation in Nutrition Tech and Generative AI at the 42nd Annual J.P. Morgan Healthcare Conference

Charting the Future of Personalized Health: A Strategic Dialogue at the Forefront of Medical Innovation


SAN FRANCISCO–(BUSINESS WIRE)–Hologram Sciences, a leader in the field of generative AI and nutrition technology, is set to attend the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, in San Francisco, California. This premier event, known as the most informative healthcare investment symposium in the industry, provides an ideal setting for Hologram Sciences to connect with global industry leaders, innovative technology creators, and members of the investment community.

Ian Brady, CEO of Hologram Sciences, leads the team’s strategic engagement at the conference, leveraging his impressive background in founding companies at the intersection of technology and consumer needs. As the co-founder of SoFi, a leader in the fintech sector, and the founder of AVA, a groundbreaking digital nutrition platform acquired by dsm-firmenich in 2019, Brady brings a wealth of experience in innovation and a deep understanding of market dynamics. Under his guidance, Hologram Sciences is poised to share valuable insights and explore the latest trends in health tech, with a particular focus on generative AI and personalized nutrition.

Hologram Sciences stands at the forefront of the rapidly evolving field of nutrition tech, which involves using advanced technologies like AI to personalize nutrition plans based on individual health data and dietary needs. Known for its innovative approach, the company will share its latest breakthroughs and insights in this domain. By integrating generative AI into personalized nutrition solutions, Hologram Sciences is not only redefining how we approach dietary health but also positioning itself as a pivotal player in shaping the future of healthcare technology.

At the conference, Hologram Sciences will demonstrate how its advanced platforms and AI-driven solutions are transforming the approach to precision wellness. The company’s presence at the event underscores its role as an industry leader in leveraging technology to address critical health challenges and improve patient outcomes.

Ian Brady, CEO of Hologram Sciences, said, “The J.P. Morgan Healthcare Conference provides an unmatched opportunity for networking and exchanging ideas within the healthcare industry. Our presence at this event highlights our dedication to leading the way in health technology, personalized nutrition, and precision wellness. We are excited to engage with fellow industry leaders and investors and shape the future of healthcare innovation, particularly in how we can further integrate targeted personalization into the healthcare ecosystem.”

The conference will enable Hologram Sciences to showcase its achievements and explore future growth opportunities, reinforcing its position at the intersection of technology and healthcare. The company looks forward to contributing to the dynamic discussions and collaborations that define the J.P. Morgan Healthcare Conference.

For potential investors and industry stakeholders searching for cutting-edge solutions in healthcare, Hologram Sciences represents a beacon of innovation and growth potential.

For meeting arrangements with Ian Brady onsite, please contact Inquiries@hologramsciences.com.

About Hologram Sciences, Inc.

Hologram Sciences is an AI-focused health tech company that helps people improve their health and wellness through innovative personalized nutrition solutions. Backed by dsm-firmenich, Hologram Sciences brings together the latest evidence-based protocols, products and pioneering technology to create holistic offerings that create positive health outcomes. Hologram Sciences is passionate about helping people overcome obstacles to feel better every day; grounded in transparency, proven clinical science, and committed to creating solutions and an organization that are fully inclusive and equitable. More information can be found at www.hologramsciences.com or via Inquiries@hologramsciences.com.

Contacts

Sarah Evans

Sevans PR

sarah@sevanspr.com

Sarah Mawji

sm@sevanspr.com

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

17 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

17 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

2 days ago